CD276 and breast cancer: Similarly, CD276-positive cell lines derived from pancreatic tumors tended to be relatively resistant, whereas those from breast cancers, colon cancers, lung cancers, and pediatric Ewing’s sarcoma were hypersensitive (Figures 4B and 4C).